About Physiometrix
Physiometrix is a Healthcare company based in Kyoto (Japan) founded in 1993, and was acquired by Hospira in June 2005. It operates as a specialized products for electrodiagnostic neurological monitoring are developed and supplied. Its focus areas include Life Sciences, Neurology, Medical Devices and Screening Devices.
Company details
Physiometrix was established in 1993 in Kyoto, Japan, within the medical technology sector. A lineup of products for electrodiagnostic neurological monitoring is produced, relying on proprietary gel materials, signal-processing electronics, and software. These tools are applied in neuro-monitoring during surgical and diagnostic procedures. Operations emphasize innovation in physiological monitoring devices for healthcare applications.
- Headquarters Kyoto, Japan
- Stage Acquired
- SectorsHealthcare
- Website physiometrix.com
- Acquired by Hospira (Jun 2005)
Funding Insights of Physiometrix
- Total Rounds 2
- Last Round Post-IPO — $8.2M
- First Round $22.5M
(Mar 2000)
All 2 funding rounds of Physiometrix with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2003 | $8.2M | Post-IPO | – | – | – |
| Mar 2000 | $22.5M | Post-IPO | – | – | – |
1 investors in total: 1 institutional.
Investors in Physiometrix
Physiometrix has secured backing from 1 investor. Prominent investors backing the company include Hospira.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Injectable drugs, infusion technologies, and biosimilars are manufactured and supplied. | 2004 | hospira.com | Lake, United States |
Investor details for Physiometrix
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Physiometrix
4 dated milestones of Physiometrix across 12 years, from founding to its latest funding, stage changes and deals.
- Founded Physiometrix is founded.
- Funding First funding round of $22.5M.
- Funding Latest funding round, Post-IPO, of $8.2M.
- Exit Acquired by Hospira.
Top companies in Neurology
10 companies that operate in the same segment as Physiometrix (Neurology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Novel biopharmaceutical medicines are developed for unmet medical needs. | 2003 | Dublin, Ireland | USD 265 M | USD 4.27 B | 2,800 | |
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 | |
Developer of therapeutics for psychiatric and neurologic diseases | 2002 | New York, New York, United States | USD 80.87 M | USD 250.31 M | 600 | |
Biologics platform developed for intracellular delivery in rare diseases. | 2016 | Boston, Massachusetts, United States | USD 175.25 M | USD 25.42 M | 183 | |
Developer of therapies for the treatment of musculoskeletal disorders | 2007 | Woburn, Massachusetts, United States | USD 62 M | USD 85.55 M | 692 | |
MR-interfaced ultrasound devices for cancer and neurology treatments are provided. | 1999 | Tirat Carmel, Haifa District, Israel | USD 574.2 M | – | 541 | |
AI-driven drug discovery platform for neurological diseases based on patients biomarkers | 2019 | San Francisco, California, United States | USD 144.72 M | – | 76 | |
Small molecule drugs for rare diseases are developed. | 1998 | South Plainfield, New Jersey, United States | USD 248.1 M | USD 1.73 B | 939 | |
Developer of small molecule therapeutics for endocrine and CNS disorders | 1992 | San Diego, California, United States | USD 10 M | USD 2.86 B | 1,800 | |
Developer of antibodies to treat complement-mediated neurodegenerative diseases | 2011 | San Francisco, California, United States | USD 256 M | – | 100 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Physiometrix
Physiometrix was founded in 1993 and raised its 1st funding round 7 years after it was founded.
Physiometrix is headquartered in Kyoto, Japan. It is registered at Kyoto, Kyoto Prefecture, Japan.
Physiometrix was established in 1993 in Kyoto, Japan, within the medical technology sector. A lineup of products for electrodiagnostic neurological monitoring is produced, relying on proprietary gel materials, signal-processing electronics, and software. These tools are applied in neuro-monitoring during surgical and diagnostic procedures. Operations emphasize innovation in physiological monitoring devices for healthcare applications.
Physiometrix has 1 investor. Key investors include Hospira.
Yes. Physiometrix was acquired by Hospira in June 2005.